Gillings epidemiologists: Undermining FDA authority on mifepristone regulation puts drug safety at risk
June 6, 2023 Drs. Juan Hincapie-Castillo and Michele Jonsson-Funk are co-authors on a new commentary expressing concern that legal challenges to the regulatory approval of mifepristone could have significant impact on the system that has ensured access to safe and effective medication in the U.S. for more than 60 years.